CD34 and myelodysplastic syndrome: Zeng et al. (70) similarly found that TLR2 was more highly expressed in the CD34+ cells of patients with lower-risk MDS compared to healthy controls or to patients with high-risk disease, and they noted that TLR2 expression correlated with increased apoptosis.